Comparative Characteristics of Efficiency and Complications of Photoselective Vaporization (120 W) and Bipolar Transuretral Resection of Prostate in Benigh Prostatic Hyperplasia
##plugins.themes.bootstrap3.article.sidebar##
##plugins.themes.bootstrap3.article.main##
Abstract
The objective: of the study was to compare the perioperative results of the use of photoselective vaporization of the prostate (PVP 120 W) and bipolar resection of the prostate in the surgical treatment of benign prostatic hyperplasia with an analysis of the effectiveness and complications of these techniques.
Materials and methods. We have been evaluating the retrospective data of patients who performed PVP or bipolar transurethral resection of the prostate (BTUR) between September 2013 and September 2016 with a volume of benign hyperplasia (BPH) < 80 cm3. Intraoperative and postoperatively analyzed duration of operation, blood loss, bedday, catheter withdrawal time, blood transfusion and other data. The International Prostate Score, Quality of Life Scale, residual urine volume and maximum rate of urination (before and after surgery) were used in the work. Observations were performed for 1, 3, 6, 12 and 18 months after surgery.
Results. In both groups, preoperative rates were similar. The decrease in hemoglobin, the duration of catheterization and bed-day were also similar in both groups. The observational data confirmed a statistically significant improvement in the International Scale of Prostate Symptoms, Quality of Life (QoL), residual urine volume and maximum rate of urination in both groups. No severe perioperative complications were observed in any of the groups, including the lack of hemotransfusion in both groups.
Conclusion. PVP (120 W) and BTUR are highly effective and safe alternatives in the surgical treatment of benign prostatic hyperplasia, including patients receiving anticoagulants.##plugins.themes.bootstrap3.article.details##
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright and grant the journal the first publication of original scientific articles under the Creative Commons Attribution 4.0 International License, which allows others to distribute work with acknowledgment of authorship and first publication in this journal.
References
Mohanty NK, Vasudeva P, Kumar A, Prakash S, Jain M, Arora RP: Photoselective vaporization of prostate vs. transurethral resection of prostate: a prospective, randomized study with one year follow-up. Indian J Urol. 2012;28:307–312. https://dx.doi.org/10.4103%2F0970-1591.102708
Ruszat R, Wyler S, Forster T, Reich O, Stief CG, Gasser TC, Sulser T, Bachmann A: Safety and effectiveness of photoselective vaporization of the prostate (PVP) in patients on ongoing oral anticoagulation. Eur Urol. 2007;51:1031–1041. https://doi.org/10.1016/j.eururo.2006.08.006
Bachmann A, Schurch L, Ruszat R, Wyler SF, Seifert HH, Muller A, Lehmann K, Sulser T: Photoselective vaporization (PVP) versus transurethral resection of the prostate ( TURP): a prospective bi-centre study of perioperative morbidity and early functional outcome. Eur Urol 2005;48:965–971. https://doi.org/10.1016/j.eururo.2005.07.001
Oelke M, Alivizatos G, Emberton M, Gravas S, Madersbacher S, Michel M, Nordling J, Rioja Sanz C, de la Rosette J: Guidelines on benign prostatic hyperplasia; in Parsons KF, Irani J, Chapple CR, Fall M, Hanus T, Llorente Abarca C, Loch T, Mitropulos D, N’Dow J, Schmidt HP, Sylvester R (eds): European Association of Urology Pocket Guidelines. Arnhem: European Association of Urology. 2009, pp 90–97.
Geavlete B, Multescu R, Dragutescu M, Jecu M, Georgescu D, Geavlete P: Transurethral resection (TUR) in saline plasma vaporization of the prostate vs standart TUR of the prostate: ‘ the better choice’ in benign prostatic hyperplasia? BJU Int. 2010;106:1695–1699. https://doi.org/10.1111/j.1464-410X.2010.09433.x
Geavlete B, Georgescu D, Multescu R, Stanescu F, Jecu M, Geavlete P: Bipolar plasma vaporization vs monopolar and bipolar TURP- a prospective, randomized, long-term comparision. Urology. 2011;78:930–935. https://doi.org/10.1016/j.urology.2011.03.072
Zhang SY, Hu H, Zhang XP, Wang D, Xu KX, Na YQ, Huang XB, Wang XF: Efficacy and safety of bipolar plasma vaporization of the prostate with ‘ button-type’ electrode compared with transurethral resection of prostate for benign prostatic hyperplasia. Chin Med J (Engl). 2012;125:3811–3814. http://dx.doi.org/10.3760/cma.j.issn.0366-6999.2012.21.012
Hermann TR, Liatsikos EN, Nagele U, Traxer O, Merseburger AS: EAU guidelines on laser technologies. Eur Urol. 2012;61:783–795. https://doi.org/10.1016/j.eururo.2012.01.010
Соrnu JN, Ahyai S, Bachmann A, de la Rosette J, Gilling P, Gratzke C, McVary K, Novara G, Woo H, Madersbacher S: A systematic review and meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic obstruction: an update. Eur Urol. 2015;67:1066–1096. https://doi.org/10.1016/j.eururo.2014.06.017
Teng J, Zhang D, Li Y, Yin L, Wang K, Cui X, Xu D: Photoselective vaporization with the green light laser vs transurethral resection of the prostate for treating benign prostate hyperplasia: a systematic review and meta-analysis. BJU Int. 2012;111:321–323. https://doi.org/10.1111/j.1464-410X.2012.11395.x
Capitan C, Blazquez C, Martin MD, Hernandez V, de la Pena E, Llorente C: Green-Light HPS 120 W laser vaporization versus transurethral resection of the prostate for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia: a randomized clinical trial with 2-year follow-up. Eur Urol. 2011;60:734–739. https://doi.org/10.1016/j.eururo.2011.05.043
Al-Ansary A, Younes N, Sampige VP, Al-Rumaihi K, Ghafouri A, Gul T, Shokeir AA: GreenLight HPS 120 W laser vaporization versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia: a randomized clinical trial with midterm followup. Eur Urol. 2010;58:349–355. https://doi.org/10.1016/j.eururo.2010.05.026
Lukacs B, Loeffler J, Bruyere F, Blanchet P, Gelet A, Coloby P, De la Taille A, Lemaire P, Baron JC, Cornu JN, Aout M, Rousseau H, Vicaut E: Photovaporization of the prostate with GreenLight 120 W laser compared with monopolar transurethral resection of the prostate: a multicenter randomized controlled trial. Eur Urol. 2012;61:1165–1173. https://doi.org/10.1016/j.eururo.2012.01.052
Robert G, de la Taille A, Hermann T: Bipolar plasma vaporization of the prostate: ready to replace GreenLight? A systematic review of randomized control trials. World J Urol. 2015;33:549–554. https://doi.org/10.1007/s00345-014-1384-4
Da Silva RD, Bidikov L, Michaels W, Gustafson D, Molina WR, Kim FJ: Bipolar energy in the treatment of benign prostatic hyperplasia: a current systematic review of the literature. Can J Urol. 2015;22(Suppl 1):30–44. PDF
Hon NH, Brathwaite D, Hussain Z, Ghiblawi S, Brace H, Hayne D, Coppinger SW: A prospective, randomized trial comparing conventional transurethral prostate resection with PlasmaKinetic vaporization of the prostate: physiological changes, early complications and long-term followup. J Urol 2006; 176: 205–209. https://doi.org/10.1016/S0022-5347(06)00492-7
Kranzbuhler B, Wettstein MS, Fankhauser CD, Grossmann NC, Gross O, Poyet C, Largo R, Fischer B, Zimmermann M, Sulser T, Muller A, Hermanns T: Pure bipolar plasma vaporization of the prostate: the Zurich experience. J Endourol 2013; 27: 1261–1266. https://doi.org/10.1089/end.2013.0335
Reich O, Bachmann A, Siebels M, Hofstetter A, Stief CG, Sulser T: High power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate in 66 high risk patients. J Urol 2005; 173: 158–160. https://doi.org/10.1097/01.ju.0000146631.14200.d4
Sandhu JS, Ng CK, Gonzales RR, Kaplan SA, Te AE: Photoselective laser vaporization prostatectomy in men receiving anticoagulants. J Endourol 2005; 19: 1196–1198. https://doi.org/10.1089/end.2005.19.1196
Pawan V, Anop K, Niraj K, Biswajit N, Punita R, Rajendra A, Nayan M: Safety and efficacy of photoselective vaporization of prostate in patients receiving anticoagulants. Minerva Urol Nephrol 2013; 65: 189–195.
Delongchamps NB, Robert G, de la Taille A, Haillot O, Balleteau C, Saussine C, Kleinclauss F, Azzouzi AR, Lukacs B, Dumonceau A, Fourmarier M, Devonec M, Descazeaud A: Surgical management of BPH in patients on oral anticoagulation: transurethral bipolar plasma vaporization in saline versus transurethral monopolar resection of the prostate. Can J Urol 2011; 18: 6007–6012.
Huang X, Wang XH, Wang HP, Qu LJ: Comparison of the microvessel diameter of hyperplastic prostate and the coagulation depth achieved with mono- and bipolar transurethral resection of the prostate. A pilot study on hemostatic capability. Scand J Urol Nephrol 2008; 42: 265–268. https://doi.org/10.1080/00365590701702168
Huang X, Wang L, Shi HB, Zhang XJ, Yu ZY: Bipolar transurethral resection of prostate causes deeper coagulation depth and less bleeding than monopolar transurethral prostatectomy. Urology 2012; 80: 1116–1120. https://doi.org/10.1016/j.urology.2012.07.024
El-Heibawy MN, Abd-allah MM, Abd Elbaky TM, Elserafy FA. Safety and efficacy of bipolar TURP in management of benign prostatic hyperplasia. Menoufia Med J 2015; 28: 225–232. https://doi.org/10.4103/1110-2098.155999
Hueber P-A, Al-Asker A, Zorn KC. Monopolar vs bipolar TURP: assessing their clinical advantages. Can Urol Assoc J 2011 Dec; 5(6): 390–391. https://dx.doi.org/10.5489%2Fcuaj.11263
Reich O. Bipolar transurethral resection of the prostate: what did we learn and where do we go from here? Eur Urol 2009; 56: 796–7. https://doi.org/10.1016/j.eururo.2009.07.029
Thangasamy IA, Chalasani V, Bachmann A, Woo HH: Photoselective vaporization of the prostate using 80 W and 120 W laser versus transurethral resection of the prostate for benign prostatic hyperplasia: a systematic review with mete-analysis from 2002 to 2012. Eur Urol 2012; 62: 315–323. https://doi.org/10.1016/j.eururo.2012.04.051
